Insight

Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery

Photo taken from Anne Knisely/LinkedIn

Aug 27, 2024, 02:59

Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery

Anne Knisely, Gynaecology and Oncology fellow at MD Anderson Cancer Center, shared a post by AJOG on X, adding:

“Excited to share our QI paper published in AJOG. If you’re not already adding metronidazole to cefazolin for SSI prophylaxis in gynaecological surgery, you should start!

Adjusted OR for SSI 0.49 decrease with addition of metronidazole.”

Quoting AJOG’s post:

“Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center.”

Source: Anne Knisely/X and AJOG/X

Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center.

Authors: Anne Knisely, Maria D. Iniesta, Claire A. Marten, Gary Chisholm, Kathleen M. Schmeler, and Jolyn S. Taylor.

Anne Knisely

AJOG Anne Knisely cancer cefazolin Claire A. Marten Gary Chisholm gynecologic surgery Jolyn S. Taylor Kathleen M. Schmeler Maria D. Iniesta Metronidazole OncoDaily Oncology SSI prophylaxis

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage